Saba Capital Management, L.P. Purchases 7,087 Shares of The Gabelli Healthcare & Wellness Trust (NYSE:GRX) Stock

The Gabelli Healthcare & Wellness Trust (NYSE:GRX) major shareholder Saba Capital Management, L.P. acquired 7,087 shares of the stock in a transaction on Friday, August 21st. The shares were bought at an average price of $10.13 per share, for a total transaction of $71,791.31. Following the purchase, the insider owned 2,150,793 shares in the company, valued at approximately $21,787,533.09. This trade represents a 0.33% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Wednesday, August 19th, Saba Capital Management, L.P. bought 24,102 shares of The Gabelli Healthcare & Wellness Trust stock. The shares were bought at an average price of $10.13 per share, with a total value of $244,153.26.
• On Friday, August 14th, Saba Capital Management, L.P. bought 1,203 shares of The Gabelli Healthcare & Wellness Trust stock. The shares were bought at an average price of $9.86 per share, with a total value of $11,861.58.
• On Tuesday, August 11th, Saba Capital Management, L.P. bought 200 shares of The Gabelli Healthcare & Wellness Trust stock. The shares were bought at an average cost of $9.93 per share, for a total transaction of $1,986.00.

The Gabelli Healthcare & Wellness Trust Stock Performance

Shares of NYSE GRX opened at $10.17 on Wednesday. The stock’s fifty day moving average is $9.63 and its 200 day moving average is $9.41. The Gabelli Healthcare & Wellness Trust has a 52 week low of $8.80 and a 52 week high of $10.20.

The Gabelli Healthcare & Wellness Trust Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Wednesday, September 16th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 6.7%. The ex-dividend date of this dividend is Wednesday, September 16th.

Institutional Trading of The Gabelli Healthcare & Wellness Trust

Institutional investors and hedge funds have recently made changes to their positions in the company. NewEdge Advisors LLC raised its holdings in The Gabelli Healthcare & Wellness Trust by 4.0% in the 4th quarter. NewEdge Advisors LLC now owns 66,689 shares of the investment management company’s stock valued at $642,000 after buying an additional 2,568 shares during the last quarter. Osaic Holdings Inc. lifted its holdings in shares of The Gabelli Healthcare & Wellness Trust by 11.3% during the second quarter. Osaic Holdings Inc. now owns 28,443 shares of the investment management company’s stock worth $269,000 after purchasing an additional 2,880 shares during the period. Aviance Capital Partners LLC grew its stake in shares of The Gabelli Healthcare & Wellness Trust by 2.1% in the first quarter. Aviance Capital Partners LLC now owns 171,325 shares of the investment management company’s stock worth $1,550,000 after purchasing an additional 3,482 shares during the last quarter. Fifth Third Bancorp bought a new stake in shares of The Gabelli Healthcare & Wellness Trust in the first quarter worth $33,000. Finally, Gamco Investors INC. ET AL increased its holdings in The Gabelli Healthcare & Wellness Trust by 1.1% in the first quarter. Gamco Investors INC. ET AL now owns 346,026 shares of the investment management company’s stock valued at $3,132,000 after purchasing an additional 3,800 shares during the period.

About The Gabelli Healthcare & Wellness Trust

The Gabelli Healthcare & Wellness Trust (NYSE: GRX) is a closed-end management investment company that seeks both capital appreciation and current income. The trust primarily invests in equity and equity-related securities of companies operating in the healthcare and wellness sectors. Trading on the New York Stock Exchange under the symbol GRX, the fund provides investors with exposure to growth opportunities in healthcare through its closed-end structure.

The trust’s portfolio is diversified across a broad range of healthcare sub-industries, including pharmaceuticals, biotechnology, medical devices, and healthcare services.